Symptom clusters and their predictors in patients with lung cancer and treated with programmed cell death protein 1 immunotherapy

OBJECTIVE: The aims of this study were to examine the symptom severity and interference among patients with lung cancer treated with PD-1 immunotherapy, explore whether those symptoms were clustered together, and identify factors associated with symptom clusters. METHODS: A cross-sectional study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guolong, Weng, Huiwen, Li, Yinghong, Li, Pingdong, Gong, Yucui, Chen, Jieya, Wei, Lin, Zeng, Linghui, Zeng, Yingchun, Cheng, Andy SK.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345784/
https://www.ncbi.nlm.nih.gov/pubmed/35935261
http://dx.doi.org/10.1016/j.apjon.2022.100103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345784/
https://www.ncbi.nlm.nih.gov/pubmed/35935261
http://dx.doi.org/10.1016/j.apjon.2022.100103

Ejemplares similares